Historical Valuation
West Pharmaceutical Services Inc (WST) is now in the Undervalued zone, suggesting that its current forward PE ratio of 36.97 is considered Undervalued compared with the five-year average of 42.33. The fair price of West Pharmaceutical Services Inc (WST) is between 286.93 to 374.09 according to relative valuation methord. Compared to the current price of 278.70 USD , West Pharmaceutical Services Inc is Undervalued By 2.87%.
Relative Value
Fair Zone
286.93-374.09
Current Price：278.70
2.87%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
West Pharmaceutical Services Inc (WST) has a current Price-to-Book (P/B) ratio of 6.51. Compared to its 3-year average P/B ratio of 8.26 , the current P/B ratio is approximately -21.18% higher. Relative to its 5-year average P/B ratio of 9.64, the current P/B ratio is about -32.46% higher. West Pharmaceutical Services Inc (WST) has a Forward Free Cash Flow (FCF) yield of approximately 1.91%. Compared to its 3-year average FCF yield of 1.65%, the current FCF yield is approximately 15.27% lower. Relative to its 5-year average FCF yield of 1.57% , the current FCF yield is about 21.73% lower.
P/B
Median3y
8.26
Median5y
9.64
FCF Yield
Median3y
1.65
Median5y
1.57
Competitors Valuation Multiple
AI Analysis for WST
The average P/S ratio for WST competitors is 4.34, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST.N) exhibits a P/S ratio of 6.20, which is 42.75% above the industry average. Given its robust revenue growth of 7.73%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for WST
1Y
3Y
5Y
Market capitalization of WST increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of WST in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is WST currently overvalued or undervalued?
West Pharmaceutical Services Inc (WST) is now in the Undervalued zone, suggesting that its current forward PE ratio of 36.97 is considered Undervalued compared with the five-year average of 42.33. The fair price of West Pharmaceutical Services Inc (WST) is between 286.93 to 374.09 according to relative valuation methord. Compared to the current price of 278.70 USD , West Pharmaceutical Services Inc is Undervalued By 2.87% .
What is West Pharmaceutical Services Inc (WST) fair value?
WST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of West Pharmaceutical Services Inc (WST) is between 286.93 to 374.09 according to relative valuation methord.
How does WST's valuation metrics compare to the industry average?
The average P/S ratio for WST's competitors is 4.34, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST) exhibits a P/S ratio of 6.20, which is 42.75% above the industry average. Given its robust revenue growth of 7.73%, this premium appears unsustainable.
What is the current P/B ratio for West Pharmaceutical Services Inc (WST) as of Jan 09 2026?
As of Jan 09 2026, West Pharmaceutical Services Inc (WST) has a P/B ratio of 6.51. This indicates that the market values WST at 6.51 times its book value.
What is the current FCF Yield for West Pharmaceutical Services Inc (WST) as of Jan 09 2026?
As of Jan 09 2026, West Pharmaceutical Services Inc (WST) has a FCF Yield of 1.91%. This means that for every dollar of West Pharmaceutical Services Inc’s market capitalization, the company generates 1.91 cents in free cash flow.
What is the current Forward P/E ratio for West Pharmaceutical Services Inc (WST) as of Jan 09 2026?
As of Jan 09 2026, West Pharmaceutical Services Inc (WST) has a Forward P/E ratio of 36.97. This means the market is willing to pay $36.97 for every dollar of West Pharmaceutical Services Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for West Pharmaceutical Services Inc (WST) as of Jan 09 2026?
As of Jan 09 2026, West Pharmaceutical Services Inc (WST) has a Forward P/S ratio of 6.20. This means the market is valuing WST at $6.20 for every dollar of expected revenue over the next 12 months.